-
Arrive AI enters into $14.97M ATM equity offering with Maxim Group
Up to $14,967,247 of common stock may be sold through Maxim as sales agent.
-
Arrive AI receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until Nov 30, 2026
Deficiency letter received June 2, 2026 for failing to maintain minimum bid price of $1.00 over 30 consecutive business days.
-
Arrive AI agrees to standstill with Streeterville Capital through Dec 31, 2026, limiting purchase notices
Investor will not deliver Purchase Notices on outstanding Pre-Paid Purchases until Dec 31, 2026, unless stock price is ≥15% above Nasdaq Minimum Price.
-
Arrive AI restates Q2/Q3 2025 on convertible note derivative error; appoints T-Mobile exec to board
Accounting error: conversion feature on Streeterville convertible notes misclassified; requires embedded derivative treatment per ASC 815-40.
-
Arrive AI receives Nasdaq deficiency notices for MVPHS and MVLS below required thresholds
MVPHS fell below $15M for 30 consecutive days through Mar 31, 2026; 180-day cure period until Sep 28, 2026.
-
Arrive AI enters $10M convertible note with Streeterville Capital at 8% interest
Principal $10.8M including $800K OID; proceeds $10M; interest 8% compounded daily.
-
Arrive AI closes $3.0M pre-paid convertible note with Streeterville Capital
Streeterville paid $3.0M for a $3.24M promissory note (8% interest, $240K OID), convertible into common shares at a discount.